Elanco Animal Health Incorporated
ELAN
Classement en actions
#1872
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Prix de l'action
$22.70
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$11.34B
Changement (1 jour)
-3.45%
Changement (1 an)
4.97%
Pays
US
Échange Elanco Animal Health Incorporated (ELAN)
Catégorie
Healthcare
Ratio P/S pour Elanco Animal Health Incorporated (ELAN)
Ratio P/S au October 2026 TTM : 2.24
Selon les derniers rapports financiers et le cours de l'action de Elanco Animal Health Incorporated, le ratio cours/ventes actuel (TTM) est 2.24. À la fin de 2023, le ratio P/S était de 1.66.
Historique du ratio P/S pour Elanco Animal Health Incorporated de 2015 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 2.24 | 66.19% |
| 2024 | 1.35 | -18.85% |
| 2023 | 1.66 | 22.76% |
| 2022 | 1.35 | -53.39% |
| 2021 | 2.90 | -29.82% |
| 2020 | 4.14 | 16.88% |
| 2019 | 3.54 | 9.72% |
| 2018 | 3.23 | -27.34% |
| 2017 | 4.44 | 0.85% |
| 2016 | 4.40 | -0.15% |
| 2015 | 4.41 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 214.59% |
IN
|
